abstract: Non-obstructive azoospermia (NOA) is one of the most severe forms of male infertility and a recent, genome-wide association study (GWAS) has identified four risk loci associated with NOA. However, a large portion of the heritability of NOA has not been well explained by GWAS. By hypothesizing that rare, low-frequency and common genetic variants might point toward a causal relation between candidate genes and NOA, we performed a two-stage study including deep exon sequencing in 96 NOA cases and 96 healthy controls and a replication study in a larger population containing 522 NOA cases and 484 healthy controls. In the solexa sequencing stage, a total of two rare mutations (chr20. 1902132 and chr20. 1902301 in SIRPA), four common mutations (rs1048055 and rs2281807 in SIRPG, rs11046992 and rs146039840 in SOX5) were identified by using next generation sequencing (NGS). In the validation stage, subjects in the NOA group had a significantly decreased frequency of the heterozygous GA genotype in SIRPA (4.23%, 22 out of 520) than that in the control group (8.60%, 41 out of 477) [odds ratios (OR) 0.47, 95% confidence intervals (CI) 0.28-0.80] (P ¼ 6.00 × 10
Introduction
Male infertility accounts for about half of all infertility cases and affects onesixth of couples worldwide (Hirsh, 2003) . A substantial proportion of male infertility is accompanied by azoospermia, most often presenting as nonobstructive azoospermia (NOA), which occurs in 1% of all adult men (Maduro and Lamb, 2002) . Some researchers have suggested that NOA may result mainly from genetic factors (Huynh et al., 2002; Ferlin et al., 2007) . Single nucleotide polymorphisms (SNPs) and other common structural variants have been reported to be associated with NOA, but often fail to replicate in independent populations (Matzuk and Lamb, 2008; Okada et al., 2008; Aston and Carrell, 2009; Navarro-Costa et al., 2010) . large portion of the heritability of complex traits has not been well explained by GWASs (Manolio et al., 2009) . One plausible explanation for missing heritability may be the loss of rare and low-frequency variants, which are not well captured by current genotyping arrays (Kryukov et al., 2007; Marth et al., 2011) . Dickson et al. have proposed that these variants might explain not only some of the heritability that is currently missing, but also that they may be the cause of a proportion of detected associations between complex traits and common SNPs from GWAS Wang et al., 2010) . Another explanation is that the common variants have small effect sizes, which do not reach genomewide significance thresholds in GWASs (Yang et al., 2010) .
To further elucidate the roles of PEX10, PRMT6, SOX5, SIRPA and SIRPG in NOA at the genomic level, we sequenced the coding region and potential functional regions of these genes to identify rare, lowfrequency and common variants that might be enriched in the NOA population and may play a role in NOA pathogenesis.
Materials and Methods

Subject recruitment and sample collection
The study was approved by the ethics review board of Nanjing Medical University. The protocols and consent forms were approved by the Institutional Review Board of Nanjing Medical University prior to the study. All participants provided their written informed consent to join in this study. And all the subjects were genetically unrelated ethnic Han-Chinese from East China. All infertile male subjects were selected on the basis of comprehensive andrological testing, including examination of medical history, physical examination, semen analysis, hormone analysis, karyotyping and Y chromosome microdeletion screening. Those with a history of cryptorchidism, vascular trauma, orchitis, obstruction of the vas deferens, vasectomy, abnormalities in chromosome number or microdeletions of the azoospermia factor region on the Y chromosome were excluded from the study (Wu et al., 2007; Lu et al., 2009) . Subjects with NOA had no sperm detected in the centrifuged pellets at three different occasions. The control subjects were fertile men from the early pregnancy registry of the same hospitals who were in the third month following a successful pregnancy. They were healthy men with normal reproductive function and confirmed having healthy babies 6 -8 months later. Eventually, 618 NOA cases and 580 matched healthy controls were recruited in our analysis.
Serum hormones analyses
The blood samples were drawn between 9:00 a.m. and 4:00 p.m. The serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testesterone (T) were determined by the radioimmunoassay kit (Beijing North Institute of Biological Technology, China). Detection limits for FSH, LH and T were 1.0 IU/l, 0.5 IU/l and 0.35 ng/ml, respectively. The normal ranges of the hormones in this kit were used as reference values.
Solexa sequencing to screen potential genetic variations
The potentially functional regions of previous GWAS-reported NOA-associated five genes were amplified using PCR in 48 overlapping fragments, by the use of the primer pairs shown in Supplementary data, Tables S1. After PCR, by the use of DNaseI (Fermentas Life sciences), a fragmented DNA sequences library of each participant was created and purified using the QIAquick purification kit (QIAGEN). After the step of DNA End-Repair and A-Tailing, the total DNA was ligated to the PE Adapter oligo mix with T4 DNA ligase and then purification followed by 2% TBE PAGE gel . The purified DNA was used directly for cluster generation and sequencing analysis using the Illumina's Solexa Sequencer according to the manufacturer's instructions. After image analysis and base calling, we received the primary data in FASTQ format. The subsequent procedures performed with Solexa were summarizing data production, evaluating sequencing quality, calculating length distribution of reads and filtrating reads contaminated. To identify single-nucleotide polymorphisms (SNPs) and indels, clean reads were aligned against hg19. SNPs and indels were identified using Samtools.
SNPscan to confirm the risk genetic variation
The SNP genotyping work was performed using a custom-by-design 2*48-Plex SNPscanTM Kit (Cat#:G0104; Genesky Biotechnologies, Inc., Shanghai, China). This kit was developed according to patented SNP genotyping technology by Genesky Biotechnologies, Inc., which was based on double ligation and multiplex fluorescence PCR (Chen et al., 2012) . And the concordance rates were .99% based on 5% duplicate samples.
Statistical analysis
Statistical analysis was carried out using the Stata 10.0 statistical package (StataCorp LP, USA). Pearson's x 2 test was used to demonstrate the differences of categorical variables such as drinking and smoking status between cases and controls. Student's t-test was used to show the differences in continuous variables such as age, body mass index (BMI) and hormones between groups. The Hardy -Weinberg equilibrium tests were performed on online software, SHEsis (http://analysis.bio-x.cn/myAnalysis.php). Estimated infertile risks with odds ratios (OR) and 95% confidence intervals (95%CI) were calculated by multivariate logistic regression. Additive model was used to direct comparison of genetic lesion frequencies between the cases and controls. Two-sided tests were used and the Bonferroni adjustment for multiple testing was applied. The applied P-value for a truly significant result is calculated as 0.05/n.
Results
Characteristics and clinical parameters of the study population
A total of 618 individuals with NOA and 580 healthy controls with proven fertility were recruited to this study. The distributions of selected characteristics and hormone levels among the case and control subjects were presented in Table I . There were no significant differences identified between case and control groups with regard to their age, smoking, drinking and BMI status. And the FSH, LH and T levels were also not significantly different between the case and control groups.
Potential functional genetic variants screening using solexa sequencing By hypothesizing that rare, low-frequency and mild-effect common genetic variants might point toward a causal relation between candidate genes and NOA, we sequenced the entire potential functional regions of the genes that comprised the NOA-associated loci, which have been identified in our previous GWAS study. Due to the exploratory nature and relatively small sample size in this analysis, P-values , 0.1 were considered statistically suggestive. The coding variants identified in the biological candidate genes through exon sequencing were shown in Table II . The distribution frequencies of two rare variants in SIRPA (chr20.1902132 and chr20.1902301), two common variants in SIRPG (rs1048055 and rs2281807) and SOX5 (rs11046992 and 146039840), respectively, were found to be different among the case and the control groups. While no significant distribution differences were found in PRMT6 and PEX10 genes.
Associations between NOA-predisposed variants and spermatogenic impairment ). The OR values suggested that the variant chr20.1902301 G.A may be a protective factor against the risk of idiopathic male infertility with NOA. As to the rs1048055 in SIRPG, the frequencies of the CC, CA and AA genotypes were 64.09 (332 out 518), 31.08 (161 out of 518) and 4.83% (25 out of 518), respectively, among the cases and 64.94 (313 out of 482), 33.82 (163 out of 482) and 1.24% (6 out of 482), respectively, among the controls. Logistic regression analysis revealed that the AA genotype, but not the CA genotype, was associated with a significantly increased risk of NOA, compared with the CC genotype (OR 3.93, 95% CI 1.59-9.70) (P ¼ 3.00 × 10
23
).
As to the other SNPs, no significant differences of distribution frequencies were identified for the variants of chr20.1902132, rs2281807, rs11046992 and rs146039840 among the NOA and the control groups.
Discussion
The search for new genetic anomalies represents one of the major tasks in modern andrology. Although the number of spermatogenesis candidate genes is steadily increasing, their pathogenic role is largely unknown. To date, few genetic variations, such as chromosome number defects, Y chromosome microdeletions and autosomal chromosome mutations, have been found to be associated with abnormal spermatogenesis and only parts of them are involved in the routine genetic analysis of oligospermic and nonobstructive azoospermic men (Krausz et al., 2004; Bashamboo et al., 2010; O'Flynn O'Brien et al., 2010) . Recently, the role of SNPs in genes potentially involved in spermatogenesis became of increasing interest. SNPs are supposed to be cofactors rather than specific causes of spermatogenic impairment because they are also present in normospermic men, although at a lower frequency. These types of genetic variants would probably be responsible for a relatively mild impairment of spermatogenesis, but the effects of these variants may be worsened by the presence of other cofactors. So identifying the genetic variations will serve as an effective strategy for discovering NOA risk alleles.
In recent years, GWAS has provided a new and powerful approach to investigate the effect of inherited genetic variation on risks of complex diseases (e.g. male infertility). The largest genetic association study in NOA performed thus far identified four loci on chromosomes 1, 12 and 20 that contain susceptibility factors for NOA . However, these GWAS-reported loci are only those that reached a stringent statistical GWAS significance criterion and explained only a small proportion of NOA risk. Based on the hypothesis that rare, lowfrequency variants, which are expected to be under purifying selection and thus enriched with deleterious, protein-coding mutations, might participate in complex traits, we sequenced the entire coding regions of the genes that comprised the NOA-associated loci to identify pathogenic rare, low-frequency variants.
In the first solexa sequencing stage, we found that rare variants in the coding sequence of SIRPA, SOX5 and SIRPG genes were associated with NOA, and may play an important role in spermatogenesis, while for the other two genes located on chromosome 1 (PEX10 and PRMT6), our results showed that there is no enrichment for rare and/or lowfrequency variants. Although these two genes (PEX10 and PRMT6) do not point toward a collection of rare and/or low-frequency coding variants being causal for NOA, it does not rule out the involvement of variants outside the coding regions of these two genes. It is also necessary to determine whether other structural variants in this region including copynumber variations, inversions or translocations play a role in the genetic contribution to NOA.
Next, we validated these potentially functional genetic variants in NOA. Our results showed that rare variants of chr20.1902301 G.A in SIRPA decreased the risk of idiopathic male infertility with NOA, while the AA genotype of rs1048055 in SIRPG increased the risk. chr20.1902301 G.A and rs1048055 are located in SIRPA and SIRPG, respectively. Proteins encoded by these two genes are members of the signal-regulatory protein (SIRP) family and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. It was reported that polymorphisms in SIRPA modulate engraftment of human hematopoietic stem cells; however, a related role in azoospermia has not been documented (Takenaka et al., 2007) . The rare variant chr20.1902301 of SIRPA is located in exon 4. In the present study, we found that the variant chr20.1902301 significantly decreased the risk of male infertility, suggesting that the genetic susceptibility may play a role in protecting against spermatogenic impairment. The precise mechanism of the variant chr20.1902301 in protecting against spermatogenic impairment remains unclear, as there is no direct functional data available for this variation. Single base substitutions may change the structure of mRNA and consequently influence their function. We therefore raised the hypothesis that this variation may be associated with mRNA secondary structure and utilized an online software, RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/ RNAfold.cgi) (Gruber et al., 2008) , to predict the secondary structure of the SIRPA mRNA sequence containing the chr20.1902301 variant (in exon 4). As shown in Supplementary data, Fig. S1 , a gross structural change was revealed. It seems a plausible explanation for our finding that the variant chr20.1902301 may change the RNA structure or the interaction of the RNA with other macromolecules. However, the relatively small sample size limited the statistical power of our study, and further functional studies with larger sample sizes are warranted to confirm our findings.
The variant of rs1048055, which is located in the 3 ′ -untranslated region, may affect gene function by altering binding activity to microRNAs. It is believed that microRNAs down-regulate gene expression by the mRNA cleavage or translational repression through base pairing in the 3 ′ UTR of messenger RNAs (mRNAs) of target genes (Lee et al., 1993) . To explore the probable mechanisms, we used the MicroSNiPer to predict the effects of this SNP on putative microRNA targets (Barenboim et al., 2010) . Predicted by MicroSNiPer, we found that, the substitution of rs1048055 C.A, abolished the original binding of miR-331-3p to the 3 ′ UTR of SIRPG, and may have increased the binding of miR-1271-5p, miR-2116-3p, miR183-5p, etc. These alternations may change the expression level of SIRPG and hence modify the susceptibility to male infertility (Supplementary data, Fig. S2 ). In summary, a two-stage study design and validation was performed to screen rare and/or low-frequency variant in target genes. Our study provides evidence of independent NOA risk alleles driven by variants in the protein-coding sequence of genes discovered by GWAS. Our findings will improve the understanding of etiology of NOA and will contribute to the development of targeted therapies.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals.org/.
